M. Matsubara et al., Effects of diethylstilbestrol on the cytogenesis of prolactin cells in thepars distalis of the pituitary gland of the mouse, CELL TIS RE, 306(2), 2001, pp. 301-307
This study was carried out to examine the developmental stage when prolacti
n cells differentiate in mice and to examine the effects of diethylstilbest
rol on the development of prolactin cells in the fetal and neonatal pituita
ry glands. A small number of immunoreactive prolactin cells appeared first
on embryonic day 15 in control (injected with oil) pituitary glands, wherea
s they did not increase in number until postnatal day 2. In diethylstilbest
rol-treated mice (5 mg/kg body weight, 24 h before killing), a small number
of immunoreactive prolactin cells were detectable as early as embryonic da
y 14, but not on day 13. They increased in number on embryonic days 15 and
16, and decreased markedly on days 17 and 18, followed by a rapid increase
after birth. This transient reduction in the response to diethylstilbestrol
was partially restored by treatment with metyrapone, a specific inhibitor
of corticosteroid production. These results suggest that in the mouse: (1)
differentiation of prolactin cells occurs between embryonic days 13 and 14,
(2) prolactin gene expression is suppressed in the nascent prolactin cells
presumably due to the presence of high levels of estrogen-binding protein,
a-fetoprotein, and (3) prolactin gene expression is also suppressed by ele
vation of circulating glucocorticoids during the perinatal period. The pres
ent results suggest that, in the mouse, at least a proportion of prolactin
cells are not derived from growth hormone cells, because the diethylstilbes
trol-induced prolactin cells appear earlier than growth hormone gene expres
sion.